Ashwani Verma
Stock Analyst at UBS
(0.94)
# 2139
Out of 5,335 analysts
76
Total ratings
48.57%
Success rate
1.22%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NBIX Neurocrine Bioscienc... | Maintains: Strong Buy | 137 152 | 117.08 | 29.83% | 8 | May 6, 2025 | |
CYTK Cytokinetics | Maintains: Neutral | 47 41 | 30.66 | 33.72% | 5 | May 2, 2025 | |
HRMY Harmony Biosciences ... | Maintains: Buy | 55 48 | 34.38 | 39.62% | 2 | Apr 28, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Buy | 25 22 | 17.21 | 27.83% | 4 | Apr 28, 2025 | |
ALKS Alkermes | Maintains: Neutral | 38 33 | 30.89 | 6.83% | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 0.83 | 26.51% | 5 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 145 179 | 103 | 73.79% | 6 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 27 | 17.48 | 54.46% | 8 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 30 34 | 37.03 | -8.18% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 14 | 9.05 | 54.7% | 2 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 415 475 | 308.18 | 54.13% | 4 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 106 114 | 58.29 | 95.57% | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 54 | 19.52 | 176.64% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 83 79 | n/a | n/a | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 107 105 | 105.66 | -0.62% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 32.78 | -14.58% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 76 81 | 31.07 | 160.7% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 7 | 78.97 | -91.14% | 1 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 209 | n/a | n/a | 2 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 8.8 | 36.36% | 2 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 0.48 | 3025% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 137 71 | n/a | n/a | 3 | Aug 4, 2022 |